Spotlight on Emerging Immunotherapy Approaches and MET Inhibitors in Advanced NSCLC is organized by Ology Medical Education, a global provider of independent medical education that develops CME initiatives for the international medical and scientific community.

This event was organized to promote the exchange and dissemination of scientific and medical information only, with no promotional activity permitted. The views expressed during each presentation are those of the speaker only, and do not necessarily reflect the views of the organizers or sponsors. The presentations may discuss therapeutic products that have not been approved, or off-label use of certain products. All content is provided for general educational purposes only and should not in any way be considered as advisory. It is the responsibility of the health care professional to verify all information and data before treating patients or using any therapies described. All presentations are for educational purposes only and should not be reproduced or distributed in any way. If you wish to reproduce, store in a retrieval system, transmit in any form or by any means (electronic, mechanical, photocopying, recording, or otherwise) any part of the material presented, you must obtain all the necessary permissions from the publisher, original author, and any other current copyright owner.

This program has been made possible thanks to an independent educational grant received from Merck KGaA, Darmstadt, Germany.

Ology Medical Education

This program was approved by the IASLC 2019 World Conference on Lung Cancer Program Committee as an independent activity held in conjunction with the IASLC 2019 World Conference on Lung Cancer. This program is not sponsored or endorsed by IASLC and is not part of the official IASLC accredited program.